Skip to content

Organic Patents®

A WordPress site dedicated to Patents and Organic Chemistry

  • Home
  • About
  • Enablement
  • Obviousness
    • Cases from the CAFC & PTAB on Small-Molecule Obviousness
    • Obviousness of Chemical Processes
    • Obviousness of Stereoisomers & Purified Compounds
  • Patent Eligibility
  • DISCLAIMER
  • Boilerplate Definitions

Pharmacosmos v. Luitpold

A pair of PTAB disputes between Pharmacosmos A/S v. Luitpold Parms. Inc should be interesting read. I’ll follow up with more detail.

IPR2015-01495

Institution Denial Finding Insufficient Evidence of Anticipation and Obviousness The National Law Review

IPR2015-01490

In Prior Art, Don’t Overlook What’s Inherently There – Wolf Greenfield blog

 

This entry was posted in Case Law and tagged inherency on March 22, 2017 by David Rucando.

Post navigation

← Concert Pharma Sells Deuterated Version of Ivacaftor to Vertex Biogen’s Tecfidera Survives PTAB Challenge →

Links

  • ACS-Chemistry & The Law
  • US Patent & Trademark Office
  • Patently-O
  • PatentDocs
  • PharmaPatents Blog

Recent Posts

  • SCHRÖDINGER’S POLYMORPH: WHEN A CRYSTALLINE FORM CLAIM IS OBVIOUS AND INVALID
  • NESACS Advances in Chemical Sciences Symposium
  • 10-Month Rule: Federally Funded Provisional Patent Applications
  • Inherency & Therapeutic Mechanisms: Reviewing In re Couvaras – (With No-Frills Diagrams)

Archives

Categories

  • Case Law
  • Chemistry
  • Deals
  • Education
  • Fun Facts
  • FYI
  • Interesting Patents
  • Patent Prosecution
  • SCOTUS
  • U.S. Supreme Court
  • Uncategorized
  • USPTO

Contact

david@organicpatents.com

Proudly powered by WordPress
Go to mobile version
Verified by MonsterInsights